EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity

Ethan P Oxley, Nadia J Kershaw, Cynthia Louis, Katharine J Goodall, Maximilian M Garwood, Skye Min Jee Ho, Veronica T F Voo, Hae-Young Park, Josephine Iaria, Lilian L L Wong, Ariel G Lebenbaum, Stephanie Wiranata und 11 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.114834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Ethan P Oxley und 22 weiteren Autor:innen. Beteiligte Einrichtung: Australian Centre for Blood Diseases, Monash University, 99 Commercial Road, Melbourne, VIC 3004, Australia. Hauptthemen laut MEDLINE: B7-H1 Antigen, B7-1 Antigen, Abatacept, T-Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: F. Hoffmann-La Roche, National Health and Medical Research Council, John T Reid Charitable Trusts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenB7-1 AntigenAbataceptT-LymphocytesHumansCTLA-4 AntigenAnimalsMiceAntigen-Presenting CellsImmunoconjugatesLymphocyte Activation

Stichwörter der Autor:innen

CD80CD86CP: ImmunologyCTLA4-IgPD-1PD-L1T cellabataceptantigen-presenting cellautoimmunityinflammation

Substanzen

B7-H1 AntigenB7-1 AntigenAbataceptCTLA-4 AntigenImmunoconjugates

Autor:innen und Institutionen

  • Australian Centre for Blood Diseases, Monash University, 99 Commercial Road, Melbourne, VIC 3004, Australia.
  • Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Royal Parade, Parkville, VIC 3052, Australia.
  • Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.
  • Department of Immunology and Pathology, Monash University, 99 Commercial Road, Melbourne, VIC 3004, Australia.
  • Department of Immunology and Pathology, Monash University, 99 Commercial Road, Melbourne, VIC 3004, Australia; Department of Allergy, Immunology & Respiratory Medicine, Monash University, Melbourne, VIC 3004, Australia.

Förderung

  • F. Hoffmann-La Roche
  • National Health and Medical Research Council
  • John T Reid Charitable Trusts
  • Bristol-Myers Squibb Company
  • Department of Health, State Government of Victoria

Zitieren

APA

Oxley, E. P., Kershaw, N. J., Louis, C., Goodall, K. J., Garwood, M. M., Jee Ho, S. M., Voo, V. T. F., Park, H. Y., Iaria, J., Wong, L. L. L., Lebenbaum, A. G., Wiranata, S., Pang, E. S., Edwards, E. S. J., D'Silva, D. B., Hansen, J., van Zelm, M. C., O'Keeffe, M., Hogarth, P. M., …, & Dickins, R. A. (2024). Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114834

Vancouver

Oxley EP, Kershaw NJ, Louis C, Goodall KJ, Garwood MM, Jee Ho SM, et al. Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114834

BibTeX
@article{Oxley2024,
  author = {Oxley, Ethan P and Kershaw, Nadia J and Louis, Cynthia and Goodall, Katharine J and Garwood, Maximilian M and Jee Ho, Skye Min and Voo, Veronica T F and Park, Hae-Young and Iaria, Josephine and Wong, Lilian L L and Lebenbaum, Ariel G and Wiranata, Stephanie and Pang, Ee Shan and Edwards, Emily S J and D'Silva, Damian B and Hansen, Jacinta and van Zelm, Menno C and O'Keeffe, Meredith and Hogarth, P Mark and Haynes, Nicole M and Huntington, Nicholas D and Wicks, Ian P and Dickins, Ross A},
  title = {Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.114834}
}
Kostenlos starten →